4.7 Article

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 174, Issue -, Pages S272-S359

Publisher

WILEY
DOI: 10.1111/bph.13877

Keywords

-

Funding

  1. Medical Research Council [G0900805] Funding Source: Medline
  2. NCI NIH HHS [R01 CA194496, R01 CA204481, R01 CA206026, R01 CA163890, P30 CA056036] Funding Source: Medline
  3. NIAAA NIH HHS [R01 AA018734] Funding Source: Medline
  4. NIDA NIH HHS [R01 DA037170] Funding Source: Medline
  5. NINDS NIH HHS [R01 NS015751, R35 NS111573] Funding Source: Medline

Ask authors/readers for more resources

The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology ( where available), plus links to an open access knowledgebase of drug targets and their ligands (www. guidetopharmacology. org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13877/full. Enzymes are one of the eightmajor pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available